Informed Decisions, Empowered Patients, And Improved Outcomes

Informed consent is one of the most important elements of clinical trials, but it can be a time-consuming and inconsistent process that places additional demands on valuable site staff.

In adopting electronic methods, guidance published by TransCelerate Biopharma, Inc. has indicated that if using eConsent, the platform should provide a detailed overview of the clinical trial process in the patient’s own language, while including guided instructions for completing the eConsent and allowing the patient to electronically sign and optionally download the signed consent document.

If all the boxes are checked, the technology-driven patient engagement feature can improve site/patient discussions and clinical trial efficiency. Learn more about how eConsent is offering a more reliable way to consent patients into a clinical trial.